PBYI
Puma Biotechnology Inc
NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY
$7.48
-0.80% today
Updated 2026-04-29
Market cap
$382.08M
P/E ratio
12.31
P/S ratio
1.67x
EPS (TTM)
$0.61
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
Puma Biotechnology Inc (PBYI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+54.4%
Last 4 quarters
Revenue YoY growth
+27.8%
Most recent quarter
EPS YoY growth
-32.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-25.8%
2026-02-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $0.29 | +7.4% | $7.68 | $5.70 | -25.8% |
| 2025-11-06 | $0.21 | +31.2% | $4.95 | $5.99 | +21.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.27 | $0.29 | +7.4% | $75.50M | +27.8% |
| 2025-09-30 | $0.16 | $0.21 | +31.2% | $54.48M | -32.4% |
| 2025-06-30 | $0.09 | $0.12 | +33.3% | $52.44M | +11.4% |
| 2025-03-31 | $-0.22 | $0.10 | +145.5% | $46.01M | +5.1% |
| 2024-12-31 | $0.14 | $0.43 | +207.1% | $59.08M | -18.2% |
| 2024-09-30 | $0.35 | $0.41 | +17.1% | $80.54M | +43.5% |
| 2024-06-30 | $-0.13 | $-0.09 | +30.8% | $47.08M | -13.7% |
| 2024-03-31 | $-0.22 | $-0.10 | +54.5% | $43.77M | -17.1% |
| 2023-12-31 | $0.30 | $0.26 | -13.3% | $72.18M | — |
| 2023-09-30 | $0.08 | $0.12 | +50.0% | $56.12M | — |
| 2023-06-30 | $0.01 | $0.05 | +400.0% | $54.57M | — |
| 2023-03-31 | $-0.07 | $0.03 | +142.9% | $52.77M | — |
Frequently asked questions
Has Puma Biotechnology Inc beaten earnings estimates?
Puma Biotechnology Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +54.4% over the last 4 quarters.
How does PBYI stock react to earnings?
PBYI stock has moved an average of -2.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Puma Biotechnology Inc's revenue growth rate?
Puma Biotechnology Inc reported year-over-year revenue growth of +27.8% in its most recent quarter, with EPS growing -32.6% year-over-year.